» Articles » PMID: 36654676

Immune Dysregulation in Immunoglobulin G4-related Disease

Overview
Publisher Elsevier
Specialty Dentistry
Date 2023 Jan 19
PMID 36654676
Authors
Affiliations
Soon will be listed here.
Abstract

(IgG4-RD) is an immune-mediated fibrotic disorder characterized by severe resolution of inflammation and dysregulation of wound healing. IgG4-RD has been considered a unique disease since 2003, and significant progress has been achieved in the understanding of its essential features. The central role of B cells in IgG4-RD has been demonstrated by the robust clinical responsiveness of IgG4-RD to B cell depletion and the identification of multiple self-antigens that promote B cell expansion. Studies have increasingly revealed critical roles of these B cells and T cells in the pathogenesis of IgG4-RD, and we and other authors further identified CD4 cytotoxic T lymphocytes as the main tissue-infiltrating CD4 T cell subset in IgG4-RD tissues. Additionally, T follicular helper cell subsets that play a role in IgG4 isotype switching have been identified. In this review, we discuss research on IgG4-RD and the roles of B cell and T cell subsets, as well as the functions of CD4 cytotoxic T cells in IgG4-RD pathogenesis. We highlight our findings from ongoing research using single-cell analysis of infiltrating CD4 cytotoxic T cells, CD4 follicular helper T cells, and infiltrating B cells in IgG4-RD and propose a model for the pathogenesis of IgG4-RD.

Citing Articles

USP18-mediated protein stabilization of NOTCH1 is associated with altered Th17/Treg cell ratios and B cell-mediated autoantibody secretion in Sjögren syndrome.

Jin X, Bai Y, Xu X, Wu F, Long X, Yao Y Immunol Res. 2024; 73(1):10.

PMID: 39672989 DOI: 10.1007/s12026-024-09566-6.


Defective LAT signalosome pathology in mice mimics human IgG4-related disease at single-cell level.

Joachim A, Aussel R, Gelard L, Zhang F, Mori D, Gregoire C J Exp Med. 2023; 220(11).

PMID: 37624388 PMC: 10457416. DOI: 10.1084/jem.20231028.

References
1.
Kaneko N, Chen H, Perugino C, Maehara T, Munemura R, Yokomizo S . Cytotoxic CD8 T cells may be drivers of tissue destruction in Sjögren's syndrome. Sci Rep. 2022; 12(1):15427. PMC: 9475031. DOI: 10.1038/s41598-022-19397-w. View

2.
Capecchi R, Italiani P, Puxeddu I, Pratesi F, Tavoni A, Boraschi D . IL-1 family cytokines and receptors in IgG4-related disease. Cytokine. 2017; 102:145-148. DOI: 10.1016/j.cyto.2017.08.001. View

3.
Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y . Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017; 542(7639):110-114. PMC: 5349321. DOI: 10.1038/nature20810. View

4.
Woodruff M, Ramonell R, Nguyen D, Cashman K, Singh Saini A, Haddad N . Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 2020; 21(12):1506-1516. PMC: 7739702. DOI: 10.1038/s41590-020-00814-z. View

5.
Carruthers M, Topazian M, Khosroshahi A, Witzig T, Wallace Z, Hart P . Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015; 74(6):1171-7. DOI: 10.1136/annrheumdis-2014-206605. View